Proteomic analysis of HEK293 cells expressing non small cell lung carcinoma associated epidermal growth factor receptor variants reveals induction of heat shock response
Open Access
- 12 June 2015
- journal article
- letter
- Published by Springer Science and Business Media LLC in Experimental Hematology & Oncology
- Vol. 4 (1), 1-4
- https://doi.org/10.1186/s40164-015-0010-5
Abstract
In view of the fact that certain non small cell lung carcinoma associated epidermal growth factor receptor mutations keep the receptor constitutively active, the downstream effectors of altered activity of mutant receptors are largely unknown. By 2D gel electrophoresis and MALDI-TOF/MS analysis, we showed that increased activity of EGFR mutants, L858R, L861Q and A871G induce heat shock proteins such as Hsp70, Hsp60, Hsp90B1, Hsp5a, Hsp71 and few transcriptional factors. Of which, Hsp70 was observed to be regulated more selectively to L861Q mutant. Our results suggest the possible role of heat shock proteins in lung tumor progression considering EGFR mutations.Keywords
Funding Information
- Indian Council of Medical Research (No. 5/13/94/2008- NCD III)
This publication has 14 references indexed in Scilit:
- EGFR Mutation and Brain Metastasis in Pulmonary AdenocarcinomasJournal of Thoracic Oncology, 2014
- Molecular epidemiology of epidermal growth factor receptor mutations in lung cancers in Indian populationIndian Journal of Cancer, 2013
- Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: A multi-institutional case–control studyClinica Chimica Acta; International Journal of Clinical Chemistry, 2012
- Genes that mediate breast cancer metastasis to the brainNature, 2009
- Increased Prevalence ofEGFR-Mutant Lung Cancer in Women and in East Asian Populations: Analysis of Estrogen-Related PolymorphismsClinical Cancer Research, 2008
- [Expression of Hsp70 Grp94 and IgG in human lung carcinoma].2008
- Lung adenocarcinomas induced in mice by mutant EGF receptors foundin human lung cancers respondto a tyrosine kinase inhibitor orto down-regulation of the receptorsGenes & Development, 2006
- EGFRMutation and Resistance of Non–Small-Cell Lung Cancer to GefitinibThe New England Journal of Medicine, 2005
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibThe New England Journal of Medicine, 2004